NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Passes Above 200-Day Moving Average of $4.66

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$4.66 and traded as high as C$5.14. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.05, with a volume of 209,259 shares changing hands.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on NWH.UN shares. BMO Capital Markets lowered their price objective on NorthWest Health Prop Real Est Inv Trust from C$6.00 to C$5.00 in a research report on Friday, February 9th. Cormark raised NorthWest Health Prop Real Est Inv Trust from a “market perform” rating to a “buy” rating in a report on Thursday, March 21st. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of C$6.29.

NorthWest Health Prop Real Est Inv Trust Stock Down 1.2 %

The company has a quick ratio of 0.06, a current ratio of 0.38 and a debt-to-equity ratio of 127.50. The stock has a 50-day simple moving average of C$4.68 and a two-hundred day simple moving average of C$4.66. The firm has a market cap of C$1.23 billion, a PE ratio of -3.53, a P/E/G ratio of 0.74 and a beta of 1.02.

NorthWest Health Prop Real Est Inv Trust Company Profile

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.